Prevalence of allelic loss at TP53 in endometrial carcinomas.
Alterations within the TP53 tumor suppressor belong to the most common genetic features reported in various human neoplasms, including endometrial cancer. In this article, the prevalence of allelic loss at the TP53 locus in primary human endometrial carcinomas (ECs) is discussed. Furthermore, we reviewed the role of allelic imbalance at 17p13.1 in metastatic human ECs on the basis of a literature review and on recently published data ascertained by our laboratory staff.
Semczuk
Andrzej
A
2nd Department of Gynecology, Lublin Medical University, PL-20-954 Lublin, Poland.
Schneider-Stock
Regine
R
Szewczuk
Wiktor
W
D000368:Aged; D000483:Alleles; D002277:Carcinoma / Q000235:genetics*; D002886:Chromosomes, Human, Pair 17; D003062:Codon; D016889:Endometrial Neoplasms / Q000235:genetics*; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D016158:Genes, p53; D006801:Humans; D019656:Loss of Heterozygosity; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010641:Phenotype; D011379:Prognosis
D003062:Codon